Enhanced desensitization and phosphorylation of the β1-adrenergic receptor in rat adipocytes by peroxovanadate

Molecular Pharmacology

Volumn 49, Issue 6, 1996, Pages 1049-1057

  Bahouth, Suleiman W ^a   Gokmen Polar, Yesim ^a   Coronel, Elizabeth C ^a   Fain, John N ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR AFFECTING AGENT; BETA 1 ADRENERGIC RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE; PEROXOVANADATE; UNCLASSIFIED DRUG; VANADIC ACID;

ADIPOCYTE; ANIMAL CELL; ARTICLE; DEPHOSPHORYLATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; INSULIN LIKE ACTIVITY; LIPOLYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR DOWN REGULATION;

ADIPOCYTES; AMINO ACID SEQUENCE; ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GLUCOSE; INSULIN; ISOPROTERENOL; LIPOLYSIS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA-1; VANADATES;

EID: 0030013568     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Malbon, C. C., F. J., Moreno, R. J. Cabelli, and J. N. Fain. Fat cell adenylate eyclase and β-adrenergic receptors in altered thyroid states. J. Biol. Chem. 253:671-678 (1978).
2. 3-adrenergic receptor Science (Washington D. C.) 245:1118-1121 (1989)
3. Hollenga, C., F. Brouwer, and J. Zaagsma. Relationship between lipolysis and cyclic AMP generation mediated by atypical β-adrenoceptors in rat adipocytes. Br. J. Pharmacol. 102:577-580 (1991).
4. Fain, J. N., and L. Rosenberg. Antilipolytic action of insulin on fat cells. Diabetes 21 (Suppl. 2):414-425 (1972).
5. Taylor, S. I., A. Cama, D. Accili, F. Barbetti, M. J. Quon, M. De La Cruz Sierra, Y. Suzuki, E. Koller, R. Levy-Toledano, E. Wertheimer, V. Y. Moncada, H. Kadowski, and T. Kadowski. Mutations in the insulin receptor gene. Endocr. Rev. 13:566-595 (1992).
6. Lonnroth, P., J. W. Eriksson, B. I. Posner, and U. Smith. Peroxovanadate but not vanadate exerts insulin-like effects in human adipocytes. Diabetologia 36:113-116 (1993).
7. Fantus, I. G., S. Kadota, G. Deragon, B. Foster, and B. I. Posner. Pervanadate [peroxide(s) of vanadate] mimics insulin action in rat adipocytes via activation of insulin receptor kinase. Biochemistry 28:8864-8871 (1989).
8. +)ATPase inhibitor. J. Biol. Chem. 255:5306-5312 (1980).
9. Mooney, R. A., K. L. Bordwell, S. Luhowskyj, and J. E. Casnelli. The insulin-like effect of vanadate on lipolysis in rat adipocytes is not accompanied by an insulin-like effect on tyrosine phosphorylation. Endocrinology 124:422-429 (1989).
10. 3-adrenoceptor-induced activation of cyclic AMP-dependent protein kinase with activation of lipolysis in rat white adipocytes. Biochem. Pharmacol. 46:575-581 (1993).
11. Inglese, J., N. J. Freedman, W. J. Koch, and R. J. Lefkowitz. Structure and mechanism of the G protein-coupled receptor kinases. J. Biol. Chem. 268:23735-23738 (1993).
12. Yuan, N., J. Friedman, B. S. Whaley, and R. B. Clark. cAMP-dependent protein kinase and protein kinase C consensus site mutations of the β-adrenergic receptor. J. Biol. Chem. 269:23032-23038 (1994).
13. Waldo, G. L., J. K. Northup, J. P. Perkins, and T. K. Harden. Characterization of an altered membrane form of the β-adrenergic receptor produced during agonist-induced desensitization. J. Biol. Chem. 258:13900-13908 (1983).
14. 2-adrenergic receptor sequestration: rescue of a sequestration-defective mutant receptor by βARK1. J. Biol. Chem. 270:24782-24789 (1995).
15. Okada, T., Y. Kawano, T. Sakakibara, O. Hazeki and M. Ui. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes: studies with a selective inhibitor wortmannin. J. Biol. Chem. 269:3568-3573 (1994).
16. Kuroda, M., R. C. Honnor, S. W. Cushman, C. Londos and I. A. Simpson. Regulation of insulin-stimulated glucose transport in the isolated rat adipocyte. J. Biol. Chem. 262:245-253 (1987).
17. Boobis, L. H., and R. J. Maughan. A simple one-step enzymatic fluorimetric method for the determination of glycerol in 20 μl of plasma. Clin. Chim. Acta 132:173-179 (1983).
18. 1-adrenergic receptor expression by suppressing transcription of the receptor gene. Biochem. J 302:397-403 (1994).
19. 1-adrenergic receptor gene in cultured ventricular myocytes. J. Biol Chem. 266:15863-15869 (1991).
20. Martensen, T. M. Chemical properties, isolation, and analysis of O-phosphates in proteins. Methods Enzymol. 107:3-23 (1984).
21. Martin, B. L., and D. J. Graves. Isotope effects on the mechanism of calcineurin catalysis: kinetic solvent isotope and isotope exchange studies. Biochim. Biophys. Acta 1206:136-142 (1994).
22. Luo, B., T. R. Hurley, and B. M. Sefton. Cyanogen bromide cleavage and proteolytic peptide mapping of proteins immobilized to membranes. Methods Enzymol. 201:149-156 (1991).
23. Granneman J. G. Effects of agonist exposure on the coupling of beta-1- and beta-2-adrenergic receptors to adenylyl cyclase in isolated adipocytes. J. Pharmacol. Exp. Ther. 261:638-642 (1992).
24. 3-adrenergic agonist. Drugs Future 19:23-26 (1994).
25. Hollenga, C., F. Brouwer, and J. Zaagsma. Differences in functional cyclic AMP compartments mediating lipolysis by isoprenaline and BRL 37344 in four adipocyte types. Eur. J. Pharmacol. 200:325-330 (1991).
26. Granneman, J. G., and C. J. Whitty. CGP-12177 modulates brown fat adenylate cyclase activity by interacting with two receptor types. J. Pharmacol Exp. Ther. 256:421-425 (1991).
27. Hausdorff, W. P., M. G. Caron, and R. J. Lefkowitz. Turning off the signal: desensitization of β-adrenergic receptor function. FASEB J. 4:2881-2889 (1990).
28. Machida, C. A., J. R. Bunzow, R. P. Searles, H. Van Tol, B. Tester, K. A. Neve, P. Teal, V. Nipper, and O. Civelli. Molecular cloning and expression of the rat β-adrenergic receptor gene. J. Biol. Chem. 265:12960-12965 (1990).
29. 2-adrenergic receptor. Proc. Natl. Acad. Sci. USA 90:3665-3669 (1993).
30. 1-adrenergic receptor. J. Biol. Chem. 259:1344-1350 (1984).
31. 2-adrenergic receptors. Proc. Natl. Acad. Sci. USA 90:10798-10802 (1993).
32. 1-adrenergic receptor: involvement of G protein-coupled receptor kinases and cyclic AMP dependent protein kinase. J. Biol. Chem. 270:17953-17961 (1995).
33. 2-adrenergic receptor are involved in distinct pathways of receptor desensitization. J. Biol. Chem. 264:12657-12665 (1989).
34. Posner, B. I., E. Faure, J. W. Burgess, A. P. Bevan, D. Lachance, G. Zhang-Sun, I. G. Fantus, J. B. Ng, D. A. Hall, B. Soo Lum, and A. Shaver. Peroxovanadium compounds: a new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics. J Biol. Chem. 269:4596-4604 (1994).
35. Swarup, G., K. V. Speeg, Jr., S. Cohen, and D. L. Garbers. Phosphotyrosyl-Protein phosphatase of TCRC-2 cells. J. Biol. Chem. 257:7298-7301 (1982).
36. Pitcher, J. A., E. S. Payne, C. Csortos, A. A. DePaoli-Roach, and R. J. Lefkowitz. The G protein-coupled receptor phosphatase: a protein phosphatase type 2A with a distinct subcellular distribution and substrate specificity. Proc. Natl. Acad. Sci. USA 92:8343-8347 (1995).
37. 1-adrenergic receptor: involvement of the cyclic AMP-dependent but not a receptor-specific protein kinase. J. Biol. Chem. 266:7462-7468 (1991).
38. Benovic, J. L., H. Kuhn, I. Weyand, J. Codina, M. G. Caron, and R. J. Lefkowitz. Functional desensitization of the isolated β-adrenergic receptor by the β-adrenergic receptor kinase: potential role for an analog of the retinal protein arrestin (48-kDa protein). Proc. Natl. Acad. Sci. USA 84:8879-8882 (1987).
39. Benovic, J. L., F. Mayor, Jr., C. Staniszewski, R. J. Lefkowitz, and M. G. Caron. Purification and characterization of the β-adrenergic receptor kinase. J. Biol. Chem. 262:9026-9032 (1987).
40. Lefkowitz, R. J. G protein-coupled receptor kinases. Cell 74:409-412 (1993).